Using VenaPro for postoperative protection against DVTs and PEs can help hospitals in several ways:
Developing a blood clot while in the hospital has been deemed a Never Event (a result that a patient should be protected against). If a patient returns to the hospital with a blood clot within 30 days after a total knee or total hip procedure, Medicare will not pay for any costs to treat on that readmission.Example: A patient develops a postoperative pulmonary embolism (a blood clot that breaks away at the site of formation, travels to the lungs and blocks an artery) after a total knee surgery. The cost to treat a pulmonary embolism is $16,644, but the average hospital profit from a total knee is $1,500, so hospital would need to perform 11 total knee procedures to recover from one Never Event.
VenaPro supplies mechanical prophylaxis sleeves to patients at risk helping prevent the formation of blood clots after discharge.
Medicare reimbursement for hospitals has changed from a pay-for-reporting model to a pay-for-performance model, broadly called Value Based Purchasing (VBP). In simpler terms, hospitals will no longer receive a flat fee for providing care; now the reimbursement will be based on the outcome of the patient’s procedure/visit. Several outcome measures will be collected such as: Did the patient develop an infection? Was appropriate heart attack care given to the patient on arrival? Was blood clot prevention ordered and administered for surgical patients? In addition, the reimbursement will also be based on patient experience and satisfaction: Was my pain managed? Did I receive clear instructions at discharge? Was my hospital room clean?
The VenaPro not only addresses the VBP outcome measure for DVTs and PE’s, but also gives the patient a Continuum of Care after leaving the hospital. The patient is better educated on their blood clot risks and has added protection after discharge. This furthers the patient’s experience with the hospital and the care provided.
Limit liability of hospitals and physicians – Death caused by a hospital’s failure to prevent blood clots, especially with high-risk patients, is a big concern for facilities and physicians. Blood clots kill more Americans each year than breast cancer, AIDs, and highway fatalities combined. With a trend towards shorter hospital stays, this is a large risk for patients after they are discharged from the facility. VenaPro sleeves help protect healthcare providers by supplying needed mechanical prophylaxis when patients are away from the watchful eye of physicians and nursing staff.
The VenaPro’s self-contained design helps to protect healthcare providers by supplying needed mechanical prophylaxis when patients are away from the care of physicians and nursing staff.
InnovaMed Health understands the importance of positive patient outcomes and experiences. VenaPro was designed to give patients a full continuum of care during the highest risk time period of a patient’s recovery. VenaPro is a self-contained compact DVT therapy device that is portable and battery-operated, providing patients with the ability to oversee their own care once they return home.
Due to VenaPro’s portability, with no separate pumps and hoses, patient’s can use it at all times ensuring maximum mobility during any phase of care, including while sitting in a vehicle after surgery. Our product was designed to provide increased patient compliance and experiences, which can translate to positive Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores.
*PE is the #1 preventable facility complication
**Johns Hopkins Medical Institute American Public Health